Expert consensus statement from six German and Austrian LVAD centers updating the DESTINE staging system to five stages, with recommendations on dressing protocols, driveline fixation, antiseptic selection, and adjunctive therapies. Published in Artificial Organs (Bernhardt et al., 2026).
Single-center cohort study of 61 HeartMate 3 LVAD patients at the Medical University of Vienna, comparing usual driveline exit-site care with and without Silverlon silver-plated dressings over six months. Published in Artificial Organs (Veiter et al., 2026).
Authors: Mini Radhakrishnan BSN, RN, CIC, Carmen M. Murphy MSN, RN, CIC, FAPIC, Kimberly E. Atrubin MPH, CIC, CPHQ, FAPIC, Lauren Wojciechowski DNP, AGACNP-BC
Tampa General Hospital
Published: American Journal of Infection Control 2024
Authors: Barbara Veiter, Martina Socha, Christiane Marko, Hebe Al Asadi, Julia Riebandt, Roxana Moayedifar, Daniel Zimpfer, Thomas Schlöglhofer Medical University of Vienna Presented: ISHLT 2026
Authors:Hannah Miller, BSN, RN, Chrystal Lewis, PhD, RN, Roma Patel, BSN, RN, Omah Odeh, BSN, RN,Sunny Varshney, MD, Erik Henricksen, PharmD, BCPS, Kiran Khush, MD, Jeffrey Teuteberg, MD Stanford Health Care, Stanford University School of Medicine Presented: ISHLT 2026
Authors: Christine Swanson, Karam R.Motawea, Erika Rogers, Tiara Narvaez, Mohammad El Diasty, Sashelin Naidoo, Yakov Elgudin, Yasir Abu-Omar University Hospitals, Cleveland Medical Center, Cleveland, Ohio, USA Presented: ISHLT 2026
Authors: Alexandra Stubblefield, BSN, RN, CES-A, E-AEC, Molly Liddell, DNP, RN, APNP, AGCNS-BC, CMSRN, Amber Stempf, BSN, RN, CES-A, Lucian Durham III, MD, PhD1;
Froedtert Hospital, Milwaukee, USA. Medical College of Wisconsin, Milwaukee, USA
AHFCCC, University of California San Francisco, San Francisco, CA, Quality Improvement, UCSF, San Francisco, CA
Presented: ISHLT 2025
